389
Views
18
CrossRef citations to date
0
Altmetric
Review

Current pharmacotherapeutic options for primary dyslipidemia in adults

ORCID Icon, , & ORCID Icon
Pages 1277-1288 | Received 07 Dec 2018, Accepted 02 Apr 2019, Published online: 06 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Amir Vahedian-Azimi, Sajad Shojaie, Maciej Banach, Farshad Heidari, Arrigo F. G. Cicero, Masoum Khoshfetrat, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants. Annals of Medicine 53:1, pages 1228-1243.
Read now
David Calderón Guzmán, Hugo Juárez Olguín, Quetzalli Veloz Corona, Maribel Ortiz Herrera, Norma Osnaya Brizuela & Gerardo Barragán Mejía. (2020) Consumption of Cooked Common Beans or Saponins Could Reduce the Risk of Diabetic Complications. Diabetes, Metabolic Syndrome and Obesity 13, pages 3481-3486.
Read now
Ronara Camila de Souza Groia Veloso, Maria Gabriela Martins Cruzeiro, Bianca Menezes Dias & Adriano Max Moreira Reis. (2020) Profile of use and access to statins in patients with coronary arterial disease in an outpatient clinic of a teaching hospital. Current Medical Research and Opinion 36:9, pages 1427-1431.
Read now
Larysa Strilchuk, Giuliano Tocci, Federica Fogacci & Arrigo F. G. Cicero. (2020) An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia. Expert Opinion on Pharmacotherapy 21:5, pages 531-539.
Read now
Larysa Strilchuk, Federica Fogacci & Arrigo Fg Cicero. (2019) Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data. Expert Opinion on Drug Safety 18:7, pages 611-621.
Read now

Articles from other publishers (13)

Michal Vrablík, Ivana Šarkanová, Katarína Breciková, Petra Šedová, Martin Šatný & Aleš Tichopád. (2023) Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias. PLOS ONE 18:5, pages e0272883.
Crossref
Federica Fogacci, Marina Giovannini, Elisa Grandi, Egidio Imbalzano, Daniela Degli Esposti, Claudio Borghi & Arrigo F. G. Cicero. (2022) Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients. Journal of Clinical Medicine 11:16, pages 4701.
Crossref
Yonglang Cheng, Tongxi Li, Peng Tan, Yichao Du, Zhiwei Huang, Hao Shi, Tianying Cai, Yifan Chen & Wenguang Fu. (2022) Efficacy and safety of the apolipoprotein C-III inhibitor Volanesorsen: a systematic evaluation and meta-analysis. Endocrine 76:2, pages 253-262.
Crossref
Naina Mohamed Pakkir Maideen. (2022) Effects of Nigella Sativa (Black seeds) Supplementation on Plasma Lipid Profile in Human Subjects - A Review. Current Nutraceuticals 3:1.
Crossref
Ann Rann Wong, Angela Wei Hong Yang, Mingdi Li, Andrew Hung, Harsharn Gill & George Binh Lenon. (2022) The Effects and Safety of Chinese Herbal Medicine on Blood Lipid Profiles in Placebo-Controlled Weight-Loss Trials: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-13.
Crossref
Eman Alefishat, Anan S. Jarab, Walid Al-Qerem & Lina Abu-Zaytoun. (2021) Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia. Healthcare 9:7, pages 813.
Crossref
Abeer M. Rababa’h, Rima Mustafa, Mo’ath Rabab’ah, Mohammad Khasawneh, Mera Ababneh, Salma Khraisha & Salah Eldien Altarabsheh. (2020) Evaluation of physician’s knowledge in Jordan about the ACC/AHA blood cholesterol guidelines. International Journal of Clinical Practice 75:3.
Crossref
Federica Fogacci, Claudio Borghi & Arrigo F. G. Cicero. (2021) Diets, Foods and Food Components’ Effect on Dyslipidemia. Nutrients 13:3, pages 741.
Crossref
Arrigo F.G. Cicero, Davide Grassi, Manfredi Rizzo & Giuliano Tocci. (2020) Drug Induced Liver Injury (DILI) due to variability in monacolin K content in Red Yeast Rice (RYR): An expert opinion. European Journal of Integrative Medicine 37, pages 101164.
Crossref
Arrigo F. G. Cicero, Federica Fogacci, Adrian V. Hernandez & Maciej Banach. (2020) Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis. PLOS Medicine 17:7, pages e1003121.
Crossref
Shinichi Nishimura & Nobuaki Matsumori. (2020) Chemical diversity and mode of action of natural products targeting lipids in the eukaryotic cell membrane. Natural Product Reports 37:5, pages 677-702.
Crossref
Federica Fogacci, Giuseppe Danilo Norata, Peter P. Toth, Marcello Arca & Arrigo F. G. Cicero. (2020) Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials. Current Atherosclerosis Reports 22:5.
Crossref
Walter Masson, Martín Lobo, Daniel Siniawski, Graciela Molinero, Melina Huerín & Juan Patricio Nogueira. (2019) Impact of Lipid-Lowering Therapy on Mortality According to the Baseline Non-HDL Cholesterol Level: A Meta-Analysis. High Blood Pressure & Cardiovascular Prevention 26:4, pages 263-272.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.